Today: 20 May 2026
SoFi (SOFI) stock jumps nearly 5% to start 2026 as Jan. 30 earnings date comes into view
4 January 2026
2 mins read

SoFi (SOFI) stock jumps nearly 5% to start 2026 as Jan. 30 earnings date comes into view

NEW YORK, January 4, 2026, 05:28 ET — Market closed

SoFi Technologies, Inc. (SOFI) shares jumped 4.9% on Friday to close at $27.46, after ending 2025 at $26.18. The Nasdaq-listed stock traded between $25.79 and $27.51 and logged about 54.8 million shares in volume, price data show.

With U.S. markets closed on Sunday, the move is the latest read on risk appetite for higher-volatility fintech names heading into the first full week of 2026. Traders have been quick to reprice the sector on shifts in interest-rate expectations, which can alter both loan demand and funding costs.

SoFi said it plans to release fourth-quarter and full-year 2025 results at about 7 a.m. ET on Jan. 30, followed by a conference call and webcast at 8 a.m. ET. The schedule sets the next near-term catalyst for a stock that has tended to swing on earnings and guidance.

Investors will look for signs that SoFi can keep growing members and deposits while keeping credit losses in check as consumers adjust to still-elevated borrowing costs. Any update to 2026 targets could also shape sentiment after a volatile year-end stretch in the shares.

The bounce in SoFi came as Wall Street opened 2026 on a firmer footing, with small-cap shares also gaining, Reuters reported. “Buy the dip, sell the rip” has been the dominant mindset, said Joe Mazzola, head of trading & derivatives strategist at Charles Schwab. Reuters

For SoFi, the rates backdrop matters because it runs a bank alongside a large consumer-lending business. Lower rates can support borrowing and refinancing activity, while changes in deposit and funding costs can affect the spread lenders earn on loans.

In its last earnings report in October, SoFi raised its 2025 forecast for adjusted earnings per share — a non-GAAP profit measure that excludes some one-time items — to about 37 cents, above analysts’ expectations, Reuters reported. The company also posted record third-quarter loan originations, the value of new loans made, of $9.9 billion, up 57% from a year earlier, the report said.

SoFi’s stock has also had to absorb equity-supply headlines. The company announced an underwritten public offering of $1.5 billion of common stock in early December, saying it intended to use proceeds for general corporate purposes including enhancing its capital position.

The competitive frame remains crowded as fintechs fight for the same digitally native customer. Traders often compare SoFi’s trajectory with peers such as Robinhood Markets and Block on engagement and cross-sell, and with online lenders like LendingClub on credit and loan growth.

Before Monday’s session, investors will also be watching the U.S. jobs report due on Jan. 9, a key data point for the Federal Reserve’s rate path, Reuters said in a weekly markets preview. A Reuters poll cited in the report forecast about 55,000 jobs added in December, a number that could sway rate-cut expectations and broader risk sentiment.

Into Jan. 30, traders will focus on loan growth, funding costs and credit performance, including net charge-offs — loans written off as uncollectible. Any commentary on how management expects rates to shape demand and margins in 2026 will be closely parsed.

Stock Market Today

  • Wall Street Price Targets: Lululemon Rated Buy, Hormel and Walker & Dunlop Marked Sell for May 2026
    May 20, 2026, 4:23 AM EDT. A recent StockStory analysis highlights Wall Street price targets for May 2026, identifying one stock recommended to buy and two to sell. Lululemon (NASDAQ:LULU) is rated a buy with a projected 47.9% return, supported by strong fundamentals. Conversely, Hormel Foods (NYSE:HRL), known for SPAM, and Walker & Dunlop (NYSE:WD) face selling pressure despite upside targets of 33.2% and 29.6%, respectively. Hormel battles declining unit sales and shrinking earnings, while Walker & Dunlop suffers from falling net interest income and equity erosion. Investors should weigh these fundamentals against price target optimism before making decisions.

Latest articles

Meiwu Technology Stock Jumps Again After 97% Surge: Why WNW Is Moving Now

Meiwu Technology Stock Jumps Again After 97% Surge: Why WNW Is Moving Now

20 May 2026
New York, May 20, 2026, 04:12 EDT Meiwu Technology Company Limited shares were bid higher before the bell on Wednesday, extending a sharp rally that nearly doubled the Nasdaq-listed stock in the prior session. WNW closed Tuesday at $4.75, up 97.10%, after trading between $3.70 and $6.39 on volume of about 51.9 million shares. In premarket trade — the early-hours session before regular U.S. trading — the stock was quoted at $5.31, up 11.79%, at 4:09 a.m. EDT. The move matters now because the rally is coming just days after Meiwu disclosed fresh financing tied to a planned AI skincare
Astera Labs Stock Surges: The AI Networking Bet Traders Are Chasing Before Nvidia Results

Astera Labs Stock Surges: The AI Networking Bet Traders Are Chasing Before Nvidia Results

20 May 2026
Astera Labs shares rose 13.3% to $244.26 on Tuesday after management outlined a faster ramp for its Scorpio X fabric switches and optical networking tied to Nvidia’s NVLink Fusion. The move followed presentations at J.P. Morgan’s tech conference and comes ahead of Nvidia’s earnings Wednesday. Astera’s first-quarter revenue jumped 93% to $308.4 million, with second-quarter guidance above analyst forecasts.
Snowflake Shares Rise Ahead of Results With AI Demand in Focus

Snowflake Shares Rise Ahead of Results With AI Demand in Focus

20 May 2026
Snowflake shares climbed 3.2% to $169.55 Tuesday after BofA Securities raised its price target to $205 and predicted strong fiscal Q1 results next week. Mizuho Securities channel checks indicated continued demand for Snowflake’s data and AI products. The company reports earnings after the market closes May 27. Recent deals include a $400 million contract and partnerships with OpenAI and Anthropic.
Spyre Therapeutics stock slides 6.6% after New Year session; $30 level and 2026 trial data in focus
Previous Story

Spyre Therapeutics stock slides 6.6% after New Year session; $30 level and 2026 trial data in focus

Baidu stock today: BIDU jumps on Kunlunxin Hong Kong IPO plan as AI-chip frenzy builds
Next Story

Baidu stock today: BIDU jumps on Kunlunxin Hong Kong IPO plan as AI-chip frenzy builds

Go toTop